Translational informatics in personalized medicine: an update for 2014

被引:0
作者
Perakslis, Eric D. [1 ,2 ,3 ]
Shon, John [4 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA 02138 USA
[2] Precis Med, Bethesda, MD USA
[3] Amer Soc Clin Oncol, Alexandria, VA USA
[4] Janssen R&D LLC, Raritan, NJ USA
关键词
big data; biomarkers; companion diagnostics; data sharing; disease stratification; informatics; personalized medicine; HEALTH INFORMATION; CYSTIC-FIBROSIS; GENOMIC MEDICINE; BIG DATA; CANCER; ONCOLOGY; DISEASE; CARE; ORGANIZATIONS; CHALLENGES;
D O I
10.2217/pme.14.8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many things have changed but much has remained the same as we have seen a dramatic increase in the generation of genetics, genomics and a variety of clinical data leading to increased data density and continued challenges in organizing and managing that data in pursuit of personalized medicine. Simultaneously, we have seen an increase in commercial and open-source solutions, and marked movement toward open sharing of tools and data in public-private partnerships, yet still few examples of traditional companion diagnostics for personalized medicine products. Most encouraging are examples of focused public and private efforts that have resulted in knowledge leading to critical assessment of existing therapies and the development of new therapies. These examples lay highly emulatable informatics foundations for rapid advances in personalized medicine.
引用
收藏
页码:339 / 349
页数:11
相关论文
共 50 条
  • [41] Update on molecular companion diagnostics-a future in personalized medicine beyond Sanger sequencing
    Campbell, Michelle Renee
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (06) : 637 - 644
  • [42] Companion diagnostics: the key to personalized medicine
    Jorgensen, Jan Trost
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (02) : 153 - 156
  • [43] Clinical Trials and Personalized Medicine in Oncology?
    Arnold, Dirk
    Bokemeyer, Carsten
    ONKOLOGIE, 2010, 33 : 25 - 29
  • [44] Personalized medicine: motivation, challenges, and progress
    Goetz, Laura H.
    Schork, Nicholas J.
    FERTILITY AND STERILITY, 2018, 109 (06) : 952 - 963
  • [45] Personalized medicine: biomarkers and companion diagnostics
    Bernardini, Renato
    Gancitano, Giovanni
    Balice, Angela
    Di Mauro, Rosaria
    Cantarella, Giuseppina
    Dionisi, Matteo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2018, 19 (01) : 21 - 26
  • [46] Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine
    Gropman, Andrea L.
    Uittenbogaard, Martine N.
    Chiaramello, Anne E.
    NEUROTHERAPEUTICS, 2024, 21 (01)
  • [47] Personalized medicine: the enabling role of nanotechnology
    Herrmann, Inge K.
    Roesslein, Matthias
    NANOMEDICINE, 2016, 11 (01) : 1 - 3
  • [48] Personalized medicine: An alternative for cancer treatment
    Singh, Devendra
    Dhiman, Vinay Kumar
    Pandey, Minakshi
    Dhiman, Vivek Kumar
    Sharma, Avinash
    Pandey, Himanshu
    Verma, Sunil Kumar
    Pandey, Rajeev
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 42
  • [49] Personalized Medicine in Psoriasis: Concept and Applications
    Al-Hoqail, Ibrahim A.
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (03) : 432 - 436
  • [50] Cancer cell transplantation in zebrafish: From translational research to personalized medicine
    Raby, Ludivine
    Volkel, Pamela
    Le Bourhis, Xuefen
    Angrand, Pierre-Olivier
    BULLETIN DU CANCER, 2020, 107 (01) : 30 - 40